| Formation of the protein corona: the interface between nanoparticles and the immune system F Barbero, L Russo, M Vitali, J Piella, I Salvo, ML Borrajo, M Busquets-Fité, ... Seminars in immunology 34, 52-60, 2017 | 245 | 2017 |
| Using nanotechnology to deliver biomolecules from nose to brain—peptides, proteins, monoclonal antibodies and RNA ML Borrajo, MJ Alonso Drug delivery and translational research, 1-19, 2022 | 25 | 2022 |
| Antibody cooperative adsorption onto AuNPs and its exploitation to force natural killer cells to kill HIV-infected T cells A Astorga-Gamaza, M Vitali, ML Borrajo, R Suárez-López, C Jaime, ... Nano Today 36, 101056, 2021 | 13 | 2021 |
| Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium L Marcos-Villar, B Perdiguero, S Anthiya, ML Borrajo, G Lou, ... npj Vaccines 9 (1), 53, 2024 | 1 | 2024 |
| Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines ML Borrajo, G Lou, S Anthiya, P Lapuhs, DM Álvarez, A Tobío, MI Loza, ... Drug Delivery and Translational Research, 1-16, 2024 | | 2024 |
| Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium L Marcos-Villar, B Perdiguero, S Anthiya, ML Borrajo, G Lou, ... npj Vaccines 9, 2024 | | 2024 |
